A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-tablet Oral Suspension and Gilteritinib Mini-tablets Compared to a Single Dose of Gilteritinib Tablet in Healthy Subjects
Clinical trial NCT03964038 · COMPLETED
Trial details
- NCT number
- NCT03964038
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-21
- Primary completion
- 2019-07-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.